
Franklin L Chen MD
Hematologic Oncology
Clinical Physician Executive, Department of Hematology Oncology, Transplant Cellular Therapy Section, Novant Health Cancer Institute
Join to View Full Profile
3333 Silas Creek PkwyWinston Salem, NC 27103
Phone+1 336-277-8800
Fax+1 336-277-8850
Dr. Chen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- Duke University HospitalFellowship, Hematology and Medical Oncology, 2006 - 2009
- UPMC Medical EducationResidency, Internal Medicine, 2003 - 2006
- Icahn School of Medicine at Mount SinaiClass of 2003
Certifications & Licensure
- NC State Medical License 2006 - 2025
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- A Study of Nivolumab Alone or Nivolumab Combination Therapy in Colon Cancer That Has Come Back or Has Spread Start of enrollment: 2014 Mar 12
- Blincyto Amgen Acrotech BioPharma PH2 Blincyto Marqibo R/R Philadelphi CD19+ ALL Start of enrollment: 2022 Jan 01
Publications & Presentations
PubMed
- 1 citationsThe effect of mobilizing large numbers of CD34 + cells (super-mobilizers) on the engraftment and survival in patients undergoing autologous stem cell transplantation.Jan S Moreb, Lori Lantos, Franklin Chen, Kathleen Elliott, James Dugan
Transfusion and Apheresis Science. 2023-12-01 - 18 citationsEfficacy and safety of first-line avelumab in patients with advanced non-small cell lung cancer: results from a phase Ib cohort of the JAVELIN Solid Tumor study.Claire F. Verschraegen, Guy Jerusalem, Edward F. McClay, Nicholas Iannotti, Charles H. Redfern
Journal for Immunotherapy of Cancer. 2020-09-01 - 132 citationsEfficacy and Safety of Avelumab Treatment in Patients With Advanced Unresectable Mesothelioma: Phase 1b Results From the JAVELIN Solid Tumor Trial.Raffit Hassan, Anish Thomas, John Nemunaitis, Manish R. Patel, Jaafar Bennouna
JAMA Oncology. 2019-03-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: